These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9863082)
1. [Clinical and experimental study on treatment of chronic hepatitis B with yanggan aoping mixture]. Yu RQ; Bi JJ; Wang QS Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Mar; 17(3):155-8. PubMed ID: 9863082 [TBL] [Abstract][Full Text] [Related]
2. [Clinical and experimental studies on effects of chronic hepatitis B treated with astragali composita]. Liu KZ; Xu CH; Zhang MT Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Jul; 16(7):394-7. PubMed ID: 9387730 [TBL] [Abstract][Full Text] [Related]
3. Effect of alcohol extract of Acanthus ilicifolius L. on anti-duck hepatitis B virus and protection of liver. Wei PH; Wu SZ; Mu XM; Xu B; Su QJ; Wei JL; Yang Y; Qin B; Xie ZC J Ethnopharmacol; 2015 Feb; 160():1-5. PubMed ID: 25446633 [TBL] [Abstract][Full Text] [Related]
4. [Clinical study on Baihua Xianglian detoxification recipe combined with adefovir dipivoxil in treating HBeAg positive chronic hepatitis]. Qiu H; Mao DW; Wei AL Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):176-9. PubMed ID: 22574587 [TBL] [Abstract][Full Text] [Related]
5. [Clinical and experimental study on yi-gan-ning granule in treating chronic hepatitis B]. Zhang BZ; Ding F; Tan LW Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Oct; 13(10):597-9, 580. PubMed ID: 8312695 [TBL] [Abstract][Full Text] [Related]
6. [Observation on effect of yugan granule in treating patients of chronic hepatitis B with basic core promoter mutant hepatitis B virus]. Xie CL; Shao ZY Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 Jul; 22(7):502-4. PubMed ID: 12592682 [TBL] [Abstract][Full Text] [Related]
7. Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection? Papatheodoridis GV; Manesis EK; Manolakopoulos S; Elefsiniotis IS; Goulis J; Giannousis J; Bilalis A; Kafiri G; Tzourmakliotis D; Archimandritis AJ Hepatology; 2008 Nov; 48(5):1451-9. PubMed ID: 18924246 [TBL] [Abstract][Full Text] [Related]
8. Anti-HBV effect of individual traditional Chinese herbal medicine in vitro and in vivo: an analytic review. Chen Y; Zhu J J Viral Hepat; 2013 Jul; 20(7):445-52. PubMed ID: 23730837 [TBL] [Abstract][Full Text] [Related]
9. [Factors associated with response to lamivudine: retrospective study of 233 patients with chronic hepatitis B]. Zhou HJ; Li SG; Wen FY; Yang XY; Wu JL; Tan B; Fu J Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):564-8. PubMed ID: 19719911 [TBL] [Abstract][Full Text] [Related]
10. Clinical and experimental effectiveness of Astragali compound in the treatment of chronic viral hepatitis B. Tang LL; Sheng JF; Xu CH; Liu KZ J Int Med Res; 2009; 37(3):662-7. PubMed ID: 19589248 [TBL] [Abstract][Full Text] [Related]
11. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B]. Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068 [TBL] [Abstract][Full Text] [Related]
12. Isolation and identification of an anti-hepatitis B virus compound from Hydrocotyle sibthorpioides Lam. Huang Q; Zhang S; Huang R; Wei L; Chen Y; Lv S; Liang C; Tan S; Liang S; Zhuo L; Lin X J Ethnopharmacol; 2013 Nov; 150(2):568-75. PubMed ID: 24051027 [TBL] [Abstract][Full Text] [Related]
13. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients. Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234 [TBL] [Abstract][Full Text] [Related]
14. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B. Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435 [TBL] [Abstract][Full Text] [Related]
15. [Inhibiting effects of root of Mallotus apelta on duck hepatitis B virus]. Xu S; Lü ZP; Cai HB; Zhang XG; Liu Q; Tan Y Zhong Xi Yi Jie He Xue Bao; 2006 May; 4(3):285-8. PubMed ID: 16696917 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus DNA prediction rules for hepatitis B e antigen-negative chronic hepatitis B. Feld JJ; Ayers M; El-Ashry D; Mazzulli T; Tellier R; Heathcote EJ Hepatology; 2007 Oct; 46(4):1057-70. PubMed ID: 17654702 [TBL] [Abstract][Full Text] [Related]
17. [Effects of entecavir and Shenxian Yiganling combination therapy on patients with HBeAg-positive chronic hepatitis B for 48 weeks]. Zhang T; Wang Y; Sun KW Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):180-2. PubMed ID: 22574588 [TBL] [Abstract][Full Text] [Related]
18. Association Between Level of Hepatitis B Surface Antigen and Relapse After Entecavir Therapy for Chronic Hepatitis B Virus Infection. Chen CH; Hung CH; Hu TH; Wang JH; Lu SN; Su PF; Lee CM Clin Gastroenterol Hepatol; 2015 Nov; 13(11):1984-92.e1. PubMed ID: 26073492 [TBL] [Abstract][Full Text] [Related]
19. Entecavir 1mg versus combined lamivudine/adefovir dipivoxil in chronic HBV Egyptian patients resistant to LAM monotherapy, non-randomised controlled study. Maklad S; Doss W; El Din SS; Hassan K; Zeid AA Arab J Gastroenterol; 2014 Mar; 15(1):1-5. PubMed ID: 24630505 [TBL] [Abstract][Full Text] [Related]
20. Predictors of hepatitis B e antigen-negative hepatitis in chronic hepatitis B virus-infected patients from childhood to adulthood. Wu JF; Chiu YC; Chang KC; Chen HL; Ni YH; Hsu HY; Chang MH Hepatology; 2016 Jan; 63(1):74-82. PubMed ID: 26389515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]